retatrutide expanded access program New Phase 3 data just dropped 👀 Eli Lilly's trial reported average weight loss approaching 30%, with some patients achieving results historically associated with bariatric surgery. A few important caveats Eli lilly will provide limited

Love Employee stock.adobe.com News Study finds faster regain than ending diet programmes GLP-1 discontinuation: weight-loss drugs work until you stop Research sounds a cautionary note for short-term use without a more comprehensive approach to weight management People tend to regain weight rapidly after stopping weight-loss drugs - and faster than after ending behavioural weight loss programmes - according to a new systematic review and meta-analysis from researchers in Oxford's Nuffield Department of Primary Care Health Sciences, published in The BMJ

Keeping peptide in lyophilized form is always the safest storage option

Costs vary widely by provider, dose, and whether a medication is brand-name or compounded

48 Given the structural absence of GLP-1R identified in human liver tissue, this appears to be a compromise